About Joshua Bilenker
Joshua Bilenker is a director at Sana Biotechnology.
Form D filings name Joshua Bilenker as an executive officer, director and promoter at Treeline Biosciences.
Joshua Bilenker reports to the SEC as a director, officer or major shareholder of 6 public companies, including Gossamer Bio (GOSS), Loxo Oncology (LOXO) and ViewRay (VRAY).
Joshua Bilenker first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Joshua Bilenker in the role, so the role may have started earlier or lasted longer.
SI
Sana Biotechnology, Inc.
Director
2021 – 2026 · Public company (SANA)
GI
Gossamer Bio, Inc.
Director
2019 – 2022 · Public company (GOSS)
LI
Loxo Oncology, Inc.
President & CEO, director
2014 – 2019 · Public company (LOXO)
VI
ViewRay, Inc.
Director and 10% owner
2016 · Public company (VRAY)
TI
T2 Biosystems, Inc.
Director
2014 – 2016 · Public company (TTOO)
RI
Roka BioScience, Inc.
Director
2014 · Public company (ROKA)
Key Colleagues at Startups
The people Joshua Bilenker works with at each company, as listed on that company's latest Form D.
Treeline Biosciences, Inc. · Form D, Sep 4, 2025
SE
Steven Elms
Director
KB
Kristina Burow
Director
DB
David Bonita
Director
JE
Jeffrey Engelman
Executive officer, director and promoter
AK
Aftab Kherani
Director
AS
Ali Satvat
Director
Avi Naider
Director
DS
David Schenkein
Director